Give us a Call
+1 (915) 412-6680
Send us a Message
[email protected]
Opening Hours
Mon-Thu: 7 AM - 7 PM
Fri - Sun: Closed

The Gut-Immune System and Hormones Role in Overall Wellness

Dive into the world of the gut-immune system and hormones and their crucial role in supporting immune health and overall wellness.

Abstract

I wrote this educational post to share how I moved from medication stacks to a systems-biology model that begins in the gut and extends through the immune, endocrine, and nervous systems. Drawing on modern methods such as metagenomic sequencing, metabolomics, intestinal permeability assays, and autonomic measures (e.g., HRV), I explain how dysbiosis, leaky gut, and LPS-driven inflammation disrupt estrogen metabolism, thyroid hormone conversion, insulin sensitivity, and mood. You will learn why supporting the estrobolome, optimizing vitamin D3–K2–A cofactors, and balancing iodine–selenium for thyroid are pivotal. I discuss practical protocols using diet, prebiotics, probiotics, butyrate support, DIM/I3C, calcium D-glucarate, glutamine, methylation cofactors, and, when appropriate, shilajit to sustain free testosterone. I also show where integrative chiropractic care fits: improving vagal tone, diaphragmatic mechanics, and autonomic balance to normalize motility, lower inflammation, and help good plans work. Throughout, I reference my clinical observations from ChiroMed and the latest findings from leading researchers, so you can see the rationale behind each step and apply this roadmap safely and effectively.

Why I Now Start With The Gut, Then Layer Hormones, Thyroid, And Structure

I trained in conventional models and spent years optimizing hormones and metabolism. I prescribed intensively, studied incretins and GLP-1, and did everything I could to improve diabetes and endocrine care. Many patients improved—but too many plateaued. The turning point came when I consistently addressed gut integrity and the neuroimmune axis first: patients’ medication burdens decreased, weight and energy normalized, and mood and cycles stabilized. When I dug deeper into the 25–30% who still struggled, I found a common thread: dysbiosis, intestinal permeability, and autonomic dysregulation blocked progress.
My clinical lesson: persistent symptoms usually reflect a convergence of microbiome imbalance, barrier dysfunction, immune activation, autonomic imbalance, and environmental mismatch. These systems converge in the gut. That’s why my care integrates functional nutrition, targeted supplementation, hormone and thyroid optimization, and integrative chiropractic to restore nervous system balance and biomechanics. Across my clinical work at ChiroMed and case reflections I share on LinkedIn, a gut-first framework reliably transforms outcomes (Jimenez, n.d.-a; Jimenez, n.d.-b).

The Gut Microbiome As A Neuroendocrine And Immune Control Center

The microbiome is a living organ system. In a healthy state, it:

  • Produces short-chain fatty acids (SCFAs)—especially butyrate, propionate, and acetate—that fuel colonocytes, tighten epithelial tight junctions, and tame inflammation (Canfora et al., 2019).
  • Trains GALT and regulatory T cells (Tregs), fostering immune tolerance (Turnbaugh & Gordon, 2019).
  • Maintains barrier integrity, preventing lipopolysaccharide (LPS) translocation and downstream TLR4–NF-κB signaling (Camilleri, 2019).
  • Modulates neurotransmitters and the HPA axis, influencing serotonin via enterochromaffin cells and stress resilience (Cryan & Dinan, 2015).
  • Shapes hormone metabolism, including the estrobolome, insulin sensitivity, and thyroid conversion.

When dysbiosis develops, we see reduced butyrate-producing bacteria, an excess of pathobionts, and elevated beta-glucuronidase—an enzyme that can deconjugate estrogens and promote estrogen recirculation. Clinically, this presents as bloating, irregular stools, acne, brain fog, fatigue, weight plateaus, and hormone therapy that “doesn’t stick.” Mechanistically, increased LPS fuels systemic inflammation and insulin resistance; reduced SCFAs loosen junctions and weaken mucosal defense; and neuroendocrine signaling drifts toward anxiety, low mood, and poor sleep.

Intestinal Permeability, Zonulin, and the Inflammation–Endocrine Loop

“Leaky gut” is a measurable phenomenon. Tight junctions—regulated by proteins like claudin, occludin, and zonulin—hold epithelial cells together. When zonulin rises in response to gluten, infections, dysbiosis, or stress, the junctions loosen, allowing dietary antigens and microbial fragments to enter the circulation (Fasano, 2012). The consequences:

  • Immune activation: Elevated TNF-α and IL-6 amplify systemic inflammation.
  • Endocrine disruption: Cytokines increase cortisol and insulin, blunt T4→T3 conversion, and alter sex hormone balance.
  • Metabolic effects: Raised insulin and cortisol promote fat storage and alter appetite circuits.

Repeated postprandial endotoxemia (LPS spikes after meals) is well documented with high-fat, ultra-processed diets, fueling insulin resistance and barrier erosion (Cani et al., 2007). In my practice, I routinely see elevated zonulin, LPS-binding protein, low SCFAs, and high beta-glucuronidase in stressed, symptomatic patients. When we seal the barrier and calm LPS, endocrine therapies begin to work the way we expect.

The Estrobolome, Beta-Glucuronidase, And Estrogen Recirculation

The estrobolome—the gut microbial genes that metabolize estrogens—determines whether estrogens are excreted or recirculated. In the liver, estrogens are conjugated (often glucuronidated) and excreted via bile. If the microbiome produces excess beta-glucuronidase, it deconjugates estrogens in the intestine, thereby enabling reabsorption through the intestinal wall (Plottel & Blaser, 2011; Flores et al., 2012). Add constipation, and you compound recirculation. Clinically, I see:

  • Worsened PMS, mastalgia, fibrocystic changes, and heavier cycles.
  • Frustration with hormone therapy due to increased metabolites returning to circulation.
  • Mood variability and breast density changes when the 2-OH:16-OH balance is unfavorable.

Supporting fiber, calcium D-glucarate, DIM/I3C, methylation cofactors, bile flow, and daily bowel movements can reverse this loop.

PCOS, Endometriosis, And The Gut–Hormone Axis

  • PCOS: Dysbiosis raises LPS and zonulin, driving inflammation and insulin resistance, which increases ovarian theca cell androgen production. Result: hyperandrogenism, anovulation, acne, and metabolic risk (Qi et al., 2022). When I rebuild the barrier, raise SCFAs, and add resistance training with targeted nutrition, fasting insulin drops, cycles stabilize, and skin clears.
  • Endometriosis: Elevated beta-glucuronidase and permeability raise circulating estrogen and pelvic inflammation. Estrogen metabolism favors 2-hydroxylation over proliferative or genotoxic pathways when supported with DIM, I3C, methylation, and glucuronidation aids (Yager & Davidson, 2006; Taylor et al., 2020). My patients often report lighter cycles and reduced pain when transit improves, and recirculation decreases.

Thyroid Conversion, Iodine–Selenium Synergy, and Hashimoto’s

Thyroid function hinges on substrate availability and redox safety:

  • Iodine is essential for T4/T3 synthesis, but it must be managed carefully—especially in autoimmune thyroiditis.
  • Selenium-dependent enzymes (glutathione peroxidases, deiodinases) detoxify H2O2 used by TPO and convert T4 to T3. Low selenium levels increase oxidative stress and can heighten antibody activity; supplementation can lower TPO antibody levels in some patients (Gärtner et al., 2002).

In Hashimoto’s, dysbiosis and intestinal permeability elevate cytokine levels, impairing T4→T3 conversion and nutrient absorption (Caturegli et al., 2014). Correcting the microbiome, supporting the barrier, and using vitamin D3–K2–A with magnesium (for vitamin D metabolism) improves immune tolerance and thyroid status. In my clinic, combining selenium (100–200 mcg/day) with gut repair and stress modulation often stabilizes symptoms and antibody trends.

Vitamin D3, K2, Magnesium, And Vitamin A: Directing Calcium And Calming Immunity

Many patients take vitamin D3 without cofactors. For safety and efficacy:

  • Magnesium supports the enzymes that convert D into its active forms.
  • Vitamin K2 (MK-7) activates osteocalcin and matrix Gla protein (MGP), directing calcium to bones and away from arteries (Beulens et al., 2013).
  • Vitamin A (retinol) works synergistically with D and K to balance bone remodeling and epithelial integrity.

I generally target 25(OH)D at 50–70 ng/mL, titrating based on labs, with D3 taken with fat and magnesium, plus K2 (and judicious vitamin A when indicated) (Pilz et al., 2019; Mitchell et al., 2022). Clinically, this reduces musculoskeletal aches, improves mood and immune balance, and safeguards vascular health during endocrine optimization.

Akkermansia, SCFAs, And Metabolic Flexibility

I pay close attention to Akkermansia muciniphila, a mucin-degrading bacterium associated with stronger mucus layers and better metabolic profiles. Low levels of Akkermansia correlate with barrier fragility and weight-loss resistance (Everard & Cani, 2013). When I support mucosal nutrition (polyphenols from berries and pomegranates; prebiotic fibers; omega-3s), Akkermansia often rebounds. When combined with fiber-induced SCFAs, patients regain insulin sensitivity, see improved fasting glucose, and break stubborn weight plateaus.

Evidence-Based Tools That Inform Personalization

Modern research methods help move from guesswork to precision:

  • Metagenomics identifies microbial composition and functional genes (e.g., SCFA producers, Enterobacteriaceae) to target interventions (Turnbaugh & Gordon, 2019).
  • Metabolomics measures functional outputs—such as SCFAs, bile acids, and indoles—to gauge progress.
  • Permeability assays (e.g., serum zonulin, lactulose/mannitol) and markers like LPS-binding protein quantify barrier function (Camilleri, 2019).
  • Neurogastroenterology and HRV assessments tailor autonomic and motility interventions (Tracey, 2002).

This data-driven approach, combined with clinical observation, improves accuracy, safety, and recovery speed.

Integrative Chiropractic Care: Why Structure And Autonomics Matter

As a chiropractor and nurse practitioner, I witness how biomechanics and the autonomic nervous system shape gut and endocrine function:

  • Vagal tone: Gentle cervical work, rib mechanics, diaphragmatic release, and paced breathing increase parasympathetic output, improving gastric accommodation and GI motility, while reducing visceral hypersensitivity.
  • Spinal and pelvic mechanics: Thoracolumbar and sacral segments modulate sympathetic and parasympathetic outflow to the GI tract; restoring mobility reduces nociceptive drive and systemic cytokine levels.
  • Movement prescriptions: Rhythmic aerobic work and resistance training improve insulin sensitivity and myokine profiles, enhancing metabolic resilience.

In my practice, adding HRV-guided breathing, diaphragmatic training, and targeted adjustments accelerates gut recovery and stabilizes mood and sleep. Structural integration is not optional; it is central to steady autonomic balance and endocrine stability (Tracey, 2002; Cryan & Dinan, 2015; Jimenez, n.d.-a; Jimenez, n.d.-b).

DIM, I3C, And Safer Estrogen Metabolism

Diindolylmethane (DIM) and indole-3-carbinol (I3C) help steer estrogen toward the 2-hydroxy (2-OH) pathway, away from 4-OH quinone-prone and 16-OH proliferative metabolites. Mechanisms include modulation of CYP enzymes and support of COMT-mediated methylation (Bradlow, 2019; Kabat et al., 2006). In practice:

  • Women: DIM 100–150 mg/day, titrating up to 300 mg/day when PMS, mastalgia, or estrogen dominance persists.
  • Men: DIM 300 mg/day, up to 600 mg/day in select prostate risk scenarios while monitoring.

I pair DIM with methylated B vitamins and sulforaphane (Nrf2 activation) to ensure conjugation and detox pathways keep pace (Singh et al., 2011). Clinically, patients report improved breast density profiles and better tolerance to HRT when DIM is maintained.

Calcium D-Glucarate, Methylation, Bile Flow, And Daily Excretion

To reduce beta-glucuronidase reactivation and enterohepatic recirculation, I use:

  • Calcium D-glucarate to support glucuronidation.
  • Methylation support (methylfolate, methylcobalamin, B6/P5P, TMG) to detoxify catechol estrogens and maintain COMT function—especially when 4-OH is elevated.
  • Bile flow support with bitters (e.g., gentian, dandelion) and hydration to carry conjugated estrogens into the intestine.
  • Transit optimization with fiber and gentle movement. Constipation is a nonstarter—daily bowel movements are mandatory for estrogen safety.

This Phase I–II–III strategy ensures metabolites are formed safely (Phase I), conjugated (Phase II), and eliminated (Phase III).

Glutamine, Zinc Carnosine, And Mucosal Repair

When permeability is high or mucosal stress is severe, I deploy:

  • L-glutamine to fuel enterocytes and bolster tight junction protein expression.
  • Zinc carnosine to stabilize mucosal surfaces and reduce oxidative stress (Ueda et al., 2007).
  • Omega-3s and demulcents as needed.

Patients often experience reduced bloating, better stool quality, and calmer skin when mucosal repair is prioritized.

Shilajit And Free Testosterone: Sustaining Benefits Across Pellet Cycles

Late in testosterone pellet cycles, many patients report symptom drift despite acceptable total testosterone. The culprit is often a decline in free testosterone, the bioavailable fraction that drives receptor signaling. Purified shilajit has shown significant increases in both total and free testosterone (e.g., ~31% and ~51% respectively at 250 mg twice daily in a randomized, placebo-controlled trial), likely via fulvic acid–mediated mitochondrial and transport effects (Pandit et al., 2016). In my clinic:
Adding purified shilajit during the latter half of a pellet cycle stabilizes free testosterone without pushing total levels into side-effect territory.
Patients report steadier energy, drive, and recovery.
I integrate shilajit into a comprehensive HRT support stack (DIM, methylated B’s, sulforaphane, CoQ10) to support balanced metabolism and oxidative protection.
For women with PCOS or androgen sensitivity, I avoid raising androgens and instead emphasize estrogen detoxification and an insulin-sensitizing lifestyle.

Practical, Stepwise Clinical Plan

Here is how I typically structure care:

  • Phase 1: Calm the fire
    • Remove ultra-processed foods, dyes, and excess alcohol.
    • Establish hydration, protein adequacy, and high-fiber, polyphenol-rich meals.
    • Start multi-strain probiotics, prebiotics (inulin, FOS, GOS, resistant starch), and L-glutamine; add zinc carnosine if mucosal stress is evident.
    • Begin paced breathing (≈6 breaths/min), humming or gargling, and chiropractic sessions to downshift sympathetic tone.
    • Target sleep: a consistent schedule, a cool, dark room, and morning light.
  • Phase 2: Restore and rebalance
    • Add DIM/I3C based on symptoms or metabolite data; support methylation (methylfolate, B12, B6, TMG).
    • Introduce calcium D-glucarate for glucuronidation; enhance transit with diverse fibers.
    • Train with progressive resistance (3x/week) and zone 2 cardio (2x/week).
    • Ensure daily bowel movements and support bile flow with bitters.
  • Phase 3: Optimize and personalize
    • Reassess stool metrics (zonulin, SCFAs, beta-glucuronidase, Akkermansia) and hormone metabolites.
    • Correct nutrient deficits (vitamin D, magnesium, omega-3s, iron, zinc).
    • Support Akkermansia with polyphenols and mucin-feeding fibers; maintain D3–K2–A for calcium handling and immune balance.
    • For pellet-based HRT, consider shilajit to sustain free testosterone; for PCOS or estrogen dominance, lean on detox supports without increasing androgens.
    • Maintain integrative chiropractic care to reinforce autonomic balance and movement quality.

Modulating Women’s Hormones- Video

Clinical Observations From My Practice

From my work at ChiroMed and professional updates I share on LinkedIn:

  • Patients with “great labs” but persistent symptoms often harbor dysbiosis, increased permeability, or elevated beta-glucuronidase—addressing these unlocks progress (Jimenez, n.d.-a; Jimenez, n.d.-b).
  • Pairing resistance training with gut repair stabilizes cycles and insulin in PCOS; skin and mood follow.
  • Akkermansia repletion tracks with breaking weight-loss plateaus, even after GLP-1 use.
  • Integrative chiropractic care improves adherence and resilience—when pain and sleep improve, nutrition and movement protocols stick, accelerating gut and hormone balance.

Why These Techniques Work: Physiology-First Reasoning

  • Prebiotics and fiber → raise SCFAs, especially butyrate, tightening junctions and lowering inflammatory signaling (Canfora et al., 2019). This reduces LPS leakage and stabilizes endocrine pathways.
  • Synbiotics (probiotics + prebiotics) → re-seed commensals and feed them, improving stool form, immune markers, and motility in IBS and dysbiosis.
  • Glutamine and zinc carnosine → restore epithelial energy and mucosal structure, lowering antigen translocation (Ueda et al., 2007).
  • DIM/I3C → steer estrogen toward 2-OH and away from 4-OH/16-OH, lowering quinone burden and proliferative signaling (Bradlow, 2019; Kabat et al., 2006).
  • Methylation support → completes detox of catechol estrogens and protects DNA via COMT and related pathways.
  • Calcium D-glucarate → promotes glucuronidation and reduces beta-glucuronidase-driven recirculation.
  • D3–K2–A with magnesium → improves immune modulation and calcium trafficking, protecting bone and vasculature (Beulens et al., 2013; Pilz et al., 2019; Mitchell et al., 2022).
  • Iodine with selenium → restores thyroid hormone synthesis while protecting against H2O2-driven oxidative damage; supports deiodinases (Gärtner et al., 2002; Zimmermann, 2003).
  • Shilajit → raises free testosterone and supports mitochondrial function, smoothing symptom curves across pellet cycles (Pandit et al., 2016).
  • Chiropractic-informed autonomic care → increases vagal tone and reduces nociception, lowering cytokines and improving motility, digestion, and sleep (Tracey, 2002; Cryan & Dinan, 2015).

Putting It All Together: A Gut-First, Whole-Person Strategy

When we respect the body’s systems biology, we see why a gut-first strategy with autonomic balance makes hormones and thyroid therapies work predictably. By:

  • Sealing the barrier and raising SCFAs,
  • Lowering LPS and cytokines,
  • Steering estrogen metabolism toward safer pathways with DIM/I3C and ensuring excretion with calcium D-glucarate, fiber, and bile flow,
  • Optimizing vitamin D3–K2–A with magnesium and carefully integrating iodine–selenium for thyroid,
  • Supporting bioavailable androgens with shilajit when appropriate,
  • And integrating chiropractic care to normalize autonomic tone and movement.

We consistently move patients from symptom management to durable health. This approach is practical, measurable, and aligned with modern, evidence-based methods. In my experience, it is also the fastest, safest way to feel well and stay well.

References


SEO tags: gut health, dysbiosis, intestinal permeability, LPS, SCFAs, estrobolome, beta-glucuronidase, estrogen metabolism, DIM, I3C, calcium D-glucarate, vitamin D3, vitamin K2, vitamin A, iodine, selenium, Hashimoto’s, thyroid conversion, Akkermansia muciniphila, shilajit, free testosterone, HRT pellets, integrative chiropractic care, vagal tone, HRV, functional medicine, microbiome sequencing, metabolomics, NF-κB, TLR4, COMT, Nrf2

Wellbeing Guide For Hormone Optimization & Metabolic Health

Discover how a clinical approach to hormone optimization can enhance your metabolic health and overall wellness.

Abstract


In this educational post, I present a clinician-focused, first-person synthesis of modern, evidence-based hormone optimization and systems biology. I integrate the latest findings from leading researchers with my clinical observations to explain how estrogen, testosterone, and progesterone regulate brain, bone, cardiovascular, metabolic, immune, and sexual health. I clarify why bioidentical 17β-estradiol and micronized progesterone differ from synthetic formulations, detail the importance of route, dose, and timing, and review metabolite safety and the gut microbiome’s influence on hormone signaling. I also outline protocols for dosing, delivery modality selection, and monitoring, and provide a systems-based framework for managing risks, side effects, and complications. My goal is to help clinicians and patients understand the mechanisms, translate research into practice, and pursue preventive, physiologic care that improves quality of life and longevity.
Keywords: hormone optimization, estrogen therapy, testosterone therapy, progesterone benefits, bioidentical hormones, transdeestradioladiol, micronized progesterone, androgen receptor, estrogen receptor, estrogen metabolites, COMT, methylation, estrobolome, microbiome, β-glucuronidase, bile acids, insulin sensitivity, bone density, cardiovascular risk, neurosteroids, sleep, erythrocytosis, prostate monitoring, VTE risk, functional medicine, clinical protocols, dosing strategies, side effect management

My Purpose and Preventive Care Perspective

As a clinician trained in functional and integrative medicine, I learned early in my career in urgent care and through exposure to end-of-life care that many emergencies arise from chronic, modifiable diseases. That realization pushed me toward proactive medicine grounded in hormone optimization and systems biology. Today, I combine peer-reviewed research with day-to-day practice insights from El Paso and beyond to deliver precise, safe, and personalized care.
I prioritize evidence-based protocols that restore physiologic ranges, avoiding supraphysiologic exposures that raise risk.
I use mechanism-first reasoning, tracing receptor pharmacology, downstream signaling, metabolic clearance, and tissue-specific effects to guide decisions.
I integrate gut and nutrient strategies to improve receptor sensitivity, metabolite profiles, and clinical outcomes.
Explore my ongoing clinical updates and case-informed reflections:

Why Mechanisms and Literature Must Drive Hormone Care

Persistent misconceptions around cancer risk, cardiometabolic outcomes, and the idea that “all hormones are the same” still influence practice. To correct these, I synthesize high-impact literature and apply physiology.
Core principle: the preventive value of hormones is context-dependent. Risks increase when the dose, delivery route, or metabolism are mismatched with patient physiology, or when monitoring is inadequate (NAMS Position Statement, 2022).
Clinical behavior:
Stratify baseline risk (family history, genomics, comorbidities).
Optimize metabolic and inflammatory terrain.
Select the lowest effective dose that restores function and quality of life while meeting biomarker targets.
This systems-first approach allows genuine prevention rather than symptom suppression.

Estrogen Optimization and Disease Prevention: Molecule, Receptor, and Route

Estrogen is not estradiol (E2), estrone (E1), or estriol (E3); these interconvert and signal via ERα, ERβ, and non-genomic pathways. These distinctions drive outcomes across organ systems.
Cardiometabolic: Estradiol improves endothelial nitric oxide synthase, dampens vascular inflammation, and influences lipoprotein profiles. Loss of E2 after menopause increases arterial stiffness and atherogenesis (Rosano et al., Endothelial effects of estrogen, 2007; Manson et al., WHI outcomes, 2013).
Skeletal: Estrogen reduces osteoclastogenesis via RANKL/OPG and supports osteoblast survival, lowering bone turnover and fracture risk (NAMS Position Statement, 2022).
Neurocognitive: E2 enhances synaptic plasticity, glucose utilization, and mitochondrial biogenesis, with neurosteroid effects modulating GABAergic tone (Brinton, Estrogen-induced plasticity, 2008; Arevalo et al., Estradiol and progesterone modulate brain inflammation, 2015).
Immune and repair: ER signaling tempers NF-κB, influences Treg activity, and supports tissue repair (Arevalo et al., 2015).

Cancer Risk, Metabolites, and Delivery

The question is not “Do hormones cause cancer?” but Whichh hormone, at what dose, via what route, in which patient, with what metabolism?””
Metabolite pathways:
2-hydroxylated estrogens are generally less proliferative.
4-hydroxylated estrogens can form catechol quinones with genotoxic potential.
16α-hydroxylated estrogens carry proliferative signals.
Favoring 2-hydroxylation and enhancing COMT-mediated methylation reduces reactive metabolite burden (Estrogen metabolites and breast cancer risk, 2012; COMT polymorphisms and cancer risk, 2004).
Route matters: Transdermal estradiol avoids hepatic first-pass induction of clotting factors and triglycerides, reducing VTE and metabolic risks compared with oral estrogens (Transdermal vs oral estrogen and vascular risk, 2016; Scarabin, Oral vs transdermal estrogen and VTE, 2003).
Progestogen pairing:
Endometrial protection requires progesterone or a progestin for women with a uterus.
Bioidentical micronized progesterone has more favorable vascular and breast profiles than certain synthetic progestins (Stanczyk et al., Progestins vs progesterone, 2013).

Clinical Protocol Logic

Start low, titrate slowly, and aim for physiologic mid-reference ranges aligned with symptom relief and biomarkers.
Prefer transdeestradiol in higher-risk or migraine-with-aura patients.
Monestradioladiol, estrone, SHBG, TSH, lipids, CRP, and urinary estrogen metabolites when indicated.
Support metabolite safety:
Dietary indoles (crucifers), omega-3s, glycine, and methyl donors as appropriate.
Clinical observation: In active women with estradiol and recurrent stress fractures, transdermal E2 combined with micronized progesterone and targeted micronutrients (calcium, vitamin D3/K2, magnesium, omega-3s) improves bone turnover markers, recovery, and mood. Adding resistance training amplifies skeletal benefits and helps with weight management. See practice insights at https://chiromed.com/ and https://www.linkedin.com/in/dralexjimenez/.

Testosterone: Anabolism, Metabolism, and Modality Selection

Testosterone reaches beyond muscle to influence erythropoiesis, insulin sensitivity, libido, bone density, mood, and immune tone. Age-related decline intersects with rising SHBG, sleep disruption, adiposity, and inflammation.
Androgen receptor dynamics:
Testosterone signals through the AR, with the balance between coactivators and corepressors affecting tissue outcomes.
Adiposity increases aromatase activity, shifting testosterone toward estradiol and altering feedback loops.
Metabolites:
Conversion to DHT via 5α-reductase impacts prostate, skin, and hair.
Peripheral conversion to E2 is essential for the bone and the brain.
Cardiometabolic:
Physiologic testosterone improves visceral adiposity, HbA1c, and triglycerides; supraphysiologic dosing increases the risk of erythrocytosis and adverse lipid profiles (Endocrine Society Guideline, 2018).

Delivery Modalities

Transdermal gels/creams: steady exposure, titration flexibility; educate on contact transfer precautions.
Injectable (e.g., cypionate): weekly or twice-weekly dosing reduces peaks and troughs affecting mood and hematology.
Subcutaneous pellets: extended release with adherence advantages; less flexible titration.
Oral undecanoate: lymphatic absorption; variable exposures.

Monitoring and Mitigation

Track total/free testosterone, Sestradioladiol, hematocrit/hemoglobin, PSA, lipids, LFTs.
Manage aromatization:
Use body composition interventions first.
Avoid routine use of aromatase inhibitors (AIs) to prevent bone and mood-related adverse effects; use only when clearly indicated.
Address erythrocytosis:
Dose-adjust; increase dosing frequency; evaluate for sleep apnea; consider phlebotomy when necessary.
Clinical observation: Men with obesity and sleep apnea respond best when CPAP adherence and resistance/interval training precede or accompany testosterone. This reduces the need for doses, stabilizes hematocrit, and improves glycemia. For peak–trough irritability, twice-weekly subcutaneous injections improve tolerability. Professional reflections shared at https://chiromed.com/ and https://www.linkedin.com/in/dralexjimenez/.

Progesterone: Neurosteroid, Sleep Modulator, and Endometrial Protector

Progesterone is a critical neurosteroid that enhances GABA-A activity, stabilizes mood and sleep, and orchestrates endometrial differentiation to oppose estrogen-driven proliferation.
Why bioidentical micronized progesterone:
CNS benefits via allopregnanolone improve sleep initiation and anxiety more consistently than some progestins.
Favorable metabolic effects on lipids and blood pressure compared to certain synthetic analogs.
Essential endometrial protection in women receiving systemic estrogen (Micronized progesterone pharmacology, 2019).
Dosing strategy:
Night dosing aligns with sedative neurosteroid effects.
In perimenopause, cyclic or continuous regimens tailored to symptoms and bleeding.
Adjust dose/route for mastalgia or fluid retention and reassess estrogen dosing and metabolites.
Clinical observation: In perimenopausal patients with sleep maintenance insomnia, nighttime micronized progesterone often reduces awakenings within 1–2 weeks. Combined with sleep hygiene and light therapy, the benefits are durable and reduce reliance on sedative-hypnotics.

Gut Health and the Estrobolome: Amplifying Hormone Receptor Activity

Hormones are effective only within a healthy terrain. The gut microbiome—especially the estrobolome—shapes estrogen recirculation, clearance, and receptor engagement.
Mechanistic links:
β-Glucuronidase excess deconjugates estrogens, driving enterohepatic recirculation and elevating certain metabolites.
Bile acid signaling via FXR and TGR5 intersects with glucose and lipid metabolism, affecting hormone sensitivity.
Barrier integrity: Increased permeability raises LPS levels, provoking TNF-α/IL-6, which can blunt hormone receptor signaling (The estrobolome and women’s health, 2019; Microbiome, bile acids, and metabolic regulation, 2014).
Clinical tools:
Diet emphasizing fiber, polyphenols, and fermented foods to diversify microbiota and modulate β-glucuronidase.
Targeted probiotics with bile salt hydrolase activity when indicated.
Consider calcium D-glucarate for high β-glucuronidase levels while addressing the root causes of diet/dysbiosis.
Support phase II detoxification with glycine, sulfur amino acids, and methyl donors.
Clinical observation: In estrogen-dominant symptom patterns with persistent mastalgia, correcting constipation, optimizing fiber/water intake, and addressing dysbiosis normalizes transit and reduces symptoms within 4–6 weeks, enabling lower hormone doses with better tolerability.

Nutrient Cofactors: Steroidogenesis, Metabolism, and Receptor Sensitivity

Robust hormone therapy requires nutrient sufficiency to support synthesis and clearance.
Zinc: Cofactor for 3β-HSD and 5α-reductase modulation; supports AR function.
Magnesium: Required for ATP-dependent enzymes in steroidogenesis and for insulin sensitivity, which influences SHBG and bioavailable hormones.
Vitamin D: Through VDR, modulates aromatase and immune tone; sufficiency enhances musculoskeletal responses to hormones (Vitamin D and testosterone interplay, 2019).
B vitamins (B2, B6, B12, folate): Support methylation and COMT for catechol estrogen clearance.
Omega-3 fatty acids: Reduce inflammatory tone, improving endothelial and receptor signaling (Omega-3s and endothelial function, 2014).
Choline and glycine: Facilitate phase II conjugation and bile acid metabolism.
Clinical observation: Correcting magnesium deficiency attenuates PVCs and improves sleep in patients starting progesterone. Addressing vitamin D insufficiency improves muscle strength responses to testosterone in older adults.

Finding Hormonal Harmony- Video

Choosing and Managing Hormone Delivery Modalities

Selecting a modality balances pharmacokinetics, safety, lifestyle, and monitoring.
Estrogen modalities:
Transdermal patches/gels: predictable PK, lower VTE risk; patches improve adherence; gels allow fine titration.
estradiol: consider only when benefits outweigh hepatic effects; monitor triglycerides and clotting risk.
Vaginal estradiol/estriol: local therapy for genitourinary syndrome; minimal systemic absorption at low doses.
Progesterone modalities:
Oral micronized progesterone: best for sleep and endometrial protection; take with a small fat-containing snack.
Vaginal progesterone: useful for uterine-focused effects or GI sensitivity.
Levonorgestrel IUD: potent endometrial suppression; useful for bleeding control with systemic estrogen.
Testosterone modalities:
Topical: cautious initiation and fine-tuning; emphasize site precautions.
Injectable: weekly/twice-weekly subcutaneous improves stability; counsel on technique.
Pellets: consider for adherence barriers; anticipate minor surgical risks and less flexible adjustments.
Monitoring cadence: baseline labs; recheck at 6–8 weeks after initiation or change; then every 3–6 months once stable; tailored to risk and symptom trajectory.

Safety, Side Effects, and Complication Management

Every protocol needs a safety net.
VTE risk: Favor transdermal estradiol; address obesity, immobility, smoking; consider thrombophilia screening when history suggests (Transdermal vs oral estrogen and vascular risk, 2016).
Breast health: Use the lowest effective estrogen dose with micronized progesterone; personalize imaging cadence and assess family history; emphasize exercise and alcohol moderation (Chlebowski et al., WHI breast cancer follow-up, 2020).
Prostate: In men, baseline PSA and DRE per guidelines; avoid initiating in untreated high-risk contexts; recheck PSA after stabilization (Endocrine Society Guideline, 2018).
Erythrocytosis: Adjust testosterone, check sleep apnea, ensure hydration; use phlebotomy only when clinically necessary (Sleep apnea and erythrocytosis, 2012).
Mood changes: Avoid sharp injection peaks; consider the topical route or adjust the frequency; evaluate sleep and micronutrient status.
Abnormal uterine bleeding: Verify endometrial protection, evaluate dosing, consider ultrasound; rule out structural causes.
Acne/hirsutism: Dose-adjust and assess DHT; consider 5α-reductase modulation case-by-case and discuss fertility.
Clinical observation: The highest-risk side effects occur when therapy starts without adequate risk stratification or when dose escalation outruns monitoring. Most complications abate with dose correction, route change, and terrain optimization.

Integrating Lifestyle, Behavior, and Shared Decision-Making

Hormones amplify what lifestyle initiates. Without sleep consolidation, resistance training, cardiorespiratory fitness, and nutritional adequacy, hormone therapy underperforms.
Exercise:
Resistance training enhances bone mineral density and insulin sensitivity.
Aerobic work improves endothelial function.
Both attenuate aromatase via fat loss (Exercise and bone metabolism, 2020).
Nutrition:
Adequate protein, fiber, and phytonutrient diversity support the microbiome and detox pathways.
Alcohol moderation reduces estrogenic load and breast risk.
Stress regulation:
Elevated cortisol undermines sex steroid signaling; mind–body practices and sleep hygiene are essential.
I emphasize shared decision-making, present risks and benefits with data, and align plans with patient values. Education transforms adherence and safety.

Practical Algorithm: Putting It All Together

Evaluate baseline: history, goals, cancer/prostate/VTE risk, sleep, mood, cardiometabolic markers, body composition, GI function.
Correct terrain: sleep, nutrition, movement, microbiome support, micronutrient deficits.
Select modality: choose delivery route aligned with risk; start low and titrate based on symptoms and labs.
Support metabolism: use diet and targeted supplements; monitor estrogen metabolites when indicated.
Monitor and adjust: schedule labs and visits; use symptom scores; adjust dose/frequency/route to sustain physiologic targets.
Prevent and manage side effects: anticipate, educate, and intervene early; document shared decisions and outcomes.

EEstrogen’sCritical Window, WHI Misconceptions, and Modern Guidelines

The Women’s Health Initiative (WHI) used conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA), not bioidentical molecules. Early risk signals were concentrated in the progestin arm, yet headlines generalized these findings to all hormones (Manson et al., WHI outcomes, 2013). Subsequent analyses demonstrated nuance:
Estrogen-alone in hysterectomized women showed neutral to beneficial patterns for some endpoints, including breast cancer incidence and mortality (Chlebowski et al., 2020).
The critical window hypothesis supports starting therapy near menopause to optimize vascular and neuroprotective effects (Maki & Henderson, Critical window, 2016).
Modern guidance emphasizes individualization, rejects routine discontinuation at age 65, and supports continuation when risk–benefit is favorable (NAMS 2017 Position Statement, 2017; NAMS 2022 Update, 2022; ACOG Practice Bulletin, 2023).
My practice aligns with these updates by prioritizing bioidentical 17β-estradiol and micronized progesterone, favoring transdermal routes, and personalizing plans.

Estradiol, Cardiovascular and Brain Protection, and Discontinuation Risks

A body of evidence indicates that appropriately destradioladiol improves vascular and metabolic health, reduces events, and supports neuroprotection:
Endothelial benefits via NO synthase activation, reduced NF-κB, improved lipids, and plaque stability (Mendelsohn & Karas, Cardiovascular effects of estrogen, 2005).
Neuroprotection through PI3K/Akt, ERK, BBB integrity preservation, and microglial modulation (Liu et al., Estradiol neuroprotection, 2007; Arevalo et al., 2015).
Abrupt estrogen withdrawal increases cardiac and stroke risks due to autonomic destabilization, vascular tone shifts, and coagulation changes; tapering is safer (Grodstein et al., HT discontinuation CV implications, 2003).
In practice, I counsel patients on continuity and, when needed, careful tapering, while maintaining protective lifestyle interventions.

Testosterone–Estradiol Synergy and Avoiding Aromatase Inhibitors in Men

Estradiol and testosterone synergize to improve lipids, insulin, and visceral fat. Routine AI use can blunt these benefits:
Bisphenol A raises pain sensitivity, worsens metabolic parameters, and undermines bone health (Henry et al., AI musculoskeletal symptoms, 2018; Handelsman, Estrogen in men’s bone health, 2013).
Allowing physiological aromatization supports the integrity of the brain, bone, vascular, and metabolic systems.
I avoid routine AIs, monestradioladiol rather than preemptively blocking it, and use body composition strategies to modulate aromatization.

Sexual Health, Genitourinary Support, and MMen’sEstrogen Balance

Estrogen influences libido, arousal, vaginal mucosa, pelvic floor, and urogenital health. In men, balaestradiol supports libido, endothelium, and bone. I pair estradiol with local therapies (e.g., vagestradiol or DHEA) and pelvic rehab when indicated, while ensuring mmen’sE2/T ratios remain physiological.

My Clinical Observations: Translating Research into Outcomes

From my practice at Chiromed and collaborative care settings:
Women initiating transdermal 17β-estradiol near menopause report rapid improvements in cognition, sleep, and vasomotor symptoms; over 6–12 months, we see improvements in lipids, lower CRP, and better glycemic metrics with nutrition and resistance training.
Adding micronized progesterone stabilizes mood and sleep; patients report deeper, more restorative rest.
Thoughtful androgen support in women can enhance energy, bone, and sexual desire; monitoring hair/skin/lipids guides dosing.
Chronic pain patients often exhibit hormonal insufficiency; corticosteroids and progesterone reduce central sensitization; when combined with myofascial care, strength training, and anti-inflammatory nutrition, outcomes improve.
Deprescribing occurs naturally: fewer sedatives as sleep normalizes, reduced antidepressants with neurosteroid support, lower antihypertensives as endothelial function and autonomic tone improve.
Explore my clinical insights:
https://chiromed.com/
https://www.linkedin.com/in/dralexjimenez/

Practical Protocol Considerations and Rationale

I design protocols to match physiology, goals, and safety:
Comprehensive assessment:
Menstrual history, vasomotor symptoms, cognition, mood, sexual health, fracture risk, cardiometabolic markers, and family history.
Estradiol:
Initiate transdermal 17β-estradiol for brain, vascular, and bone signaling due to receptor congruence and lower thrombotic risk.
Progesterone:
Add oral micronized progesterone for uterine protection and neurocalm; avoid progestins due to their receptor promiscuity and immune effects.
Androgens:
Consider low-dose testosterone in women for bone, muscle, and libido with careful monitoring; in men, maintain physiologic dosing and avoid routine AIs.
Lifestyle medicine:
Progressive resistance training, zone-2 cardio, sleep optimization, stress management, and a phytonutrient-rich diet.
Gut–hormone axis:
Address dysbiosis, increase fiber and polyphenol intake, support liver detoxification, and normalize enterohepatic cycling.
Monitoring:
Track symptoms, vitals, lipids, CRP, glucose/insulin, DEXA, endometrial status, and cognitive screening as needed.
Each element is chosen to advance patient goals and respect biological signaling.

Myths and Misconceptions Corrected


strogen causes breast cancer.””Evidence differentiates molecules: risks increased with progestin combinations started late in WHI; estrogen-alone data show neutral/beneficial patterns in specific groups. Bioidentestradiol with progesterone is distinct from CEE+MPA (Chlebowski et al., 2020; NAMS 2022 Update, 2022).
“”ll hormones are the same.””False. 17β-estradiol and micronized progesterone are physiologically coherent; synthetic analogs have different receptor promiscuity and effects (Stanczyk et al., 2013).
“top at 65.” Not evidence-based; discontinuation reverses gains. Continuation should be individualized (NAMS 2017 Position Statement, 2017; NAMS 2022 Update, 2022).
“Only treat hot flashes.””Estrogen is a longevity hormone that affects the brain, bones, heart, immune system, and sexual health.

Conclusion: Modern, Evidence-Based Hormone Optimization

Estrogen, specifically 17β-estradiol, paired with micronized progesterone, and testosterone where appropriate, supports neuroprotection, bone strength, cardiovascular resilience, immune modulation, and sexual vitality. Outcomes depend on molecule, route, dose, timing, and systemic context. By embracing modern evidence and systems biology, we can reduce polypharmacy, elevate quality of life, and practice true preventive medicine.

References

About Dr. Alexander Jimenez

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, provides integrative, functional, and evidence-based musculoskeletal and metabolic care. Clinical insights and educational resources are available at:
https://chiromed.com/
https://www.linkedin.com/in/dralexjimenez/

Keywords


hormone optimization, estrogen therapy, testosterone therapy, progesterone benefits, bioidentical hormones, transdeestradioladiol, micronized progesterone, androgen receptor, estrogen receptor, estrogen metabolites, COMT, methylation, estrobolome, microbiome, β-glucuronidase, bile acids, insulin sensitivity, bone density, cardiovascular risk, neurosteroids, sleep, erythrocytosis, prostate monitoring, VTE risk, functional medicine, clinical protocols, dosing strategies, side effect management, longevity, preventive medicine

Disclaimer


This educational content is for informational purposes only and does not constitute medical advice. Do not start, stop, or change any medication or therapy without consulting your qualified healthcare provider.

SEO tags: hormone optimization, bioidentestradiol, micronized progesterone, transdermal estrogen safety, testosterone therapy men, aromatase inhibitors risks, menopause brain health, dementia prevention estrogen, cardiovascular endothelial function estrogen, bone density menopause therapy, estrobolome gut hormones, functional medicine hormone therapy, VTE risk transdermal estrogen, progesterone neurosteroid sleep, erythrocytosis testosterone management, Dr. Alexander Jimenez DC APRN FNP-BC, evidence-based endocrinology, WHI misconceptions and modern guidelines, NAMS hormone therapy position, androgen therapy women, deprescribing with hormone optimization

The Clinical Approach to Endocrine Health & Hormonal Balance

Learn about hormone optimization and its impact on health in this comprehensive look at the clinical approach to hormonal balance.

Introduction & Abstraction

As a Doctor of Chiropractic (DC) and a board-certified Family Nurse Practitioner (FNP-BC, APRN), I have pursued a clinical journey of continuous learning and integration. At our clinic, Injury Medical & Chiropractic Clinic, we observe the complex interplay of the human body daily. This educational post distills that experience and combines it with the groundbreaking work of leading researchers in functional and integrative medicine. We will move beyond the traditional, symptom-based model to explore the deep physiological underpinnings of health and disease. This is not a lecture, but a narrative exploration of modern, evidence-based research, designed to empower both practitioners and the health-conscious public.
Our journey begins at the cellular level, examining the critical role of the cell membrane. We will explore how its health, particularly the balance of essential fatty acids such as Omega-6 and Omega-3, dictates the body’s inflammatory state. You will learn why the standard Western diet, with its skewed fatty acid ratio, is a primary driver of chronic, low-grade inflammation, and how this “silent” inflammation is the bedrock for a host of chronic diseases, from cardiovascular conditions to autoimmune disorders. We will dissect the biochemical pathways of eicosanoids, understanding how arachidonic acid (an Omega-6 fatty acid) fuels pro-inflammatory cascades, while EPA and DHA (Omega-3 Fatty Acids) generate powerful anti-inflammatory and pro-resolving molecules called resolvins and protectins.
From there, we will transition to the gut, the “second brain” and the epicenter of our immune system. We will delve into the concept of intestinal permeability, or “leaky gut,” and explain how a compromised gut barrier allows undigested food particles, toxins, and bacterial components such as lipopolysaccharides (LPS) to enter the bloodstream. This breach triggers a systemic inflammatory response that can manifest in myriad ways, including joint pain, brain fog, skin issues, and autoimmune flare-ups. We will discuss the crucial role of the gut microbiome and how imbalances, or dysbiosis, contribute to this breakdown. Furthermore, we will illuminate the critical connection between gut health and hormonal balance, with a specific focus on the estrobolome—the collection of gut bacteria capable of metabolizing estrogens—and its profound impact on conditions such as estrogen dominance.
Finally, we will integrate these concepts into a holistic clinical framework. We will discuss the vital importance of detoxification, not as a fad but as a fundamental biological process essential for clearing hormonal metabolites, environmental toxins, and inflammatory byproducts. We’ll examine the phases of liver detoxification and the key nutrients required for their optimal function. This comprehensive understanding leads us to the 4R Program for gut restoration—Remove, Replace, Reinoculate, and Repair—a systematic, evidence-based protocol to heal the gut lining, rebalance the microbiome, and quench systemic inflammation. Through this detailed exploration, we aim to provide a clear, actionable roadmap for understanding and addressing the root causes of chronic illness, moving from cellular inflammation to systemic wellness. This is the future of proactive, personalized healthcare.

Navigating the Modern Health Landscape: A Clinician’s Perspective


Welcome. As both a chiropractor and a family nurse practitioner, I stand at a unique crossroads in healthcare. My days are filled with the narratives of patients whose stories, while unique, often share common threads of chronic pain, fatigue, and a frustrating search for answers. At our clinic, we’ve learned that looking at the site of pain is only the beginning. The real story is often written at a much deeper, cellular level. The purpose of this discussion is to share with you what we, as clinicians and researchers, are learning about the fundamental drivers of health and disease in the 21st century. We’re moving past the “a pill for every ill” mindset and into a new era of evidence-based, systems-based medicine. We are not just managing symptoms; we are investigating and addressing the root causes.
The insights I’m presenting today are not just my own but are built upon the pioneering work of leading researchers in functional medicine. These are the individuals meticulously mapping the biochemical pathways that connect our diet, environment, and genes to our overall health. Through modern, evidence-based research methods—from randomized controlled trials to advanced metabolomic profiling—they are providing the “why” behind what we observe clinically. My goal is to translate this complex science into a clear, understandable narrative, weaving in my own clinical observations to illustrate how these concepts play out in real people. We will journey from the microscopic world of the cell membrane to the complex ecosystem of the gut, and finally, to the systemic influence of our hormones, creating a holistic map of human health.

The Cell Membrane: Ground Zero for Inflammation

When a patient comes into my office with chronic joint pain, brain fog, or persistent fatigue, my investigation begins at the most fundamental unit of their body: the cell. More specifically, I focus on the cell membrane. This isn’t just a passive bag holding the cell’s contents; it’s a dynamic, intelligent gatekeeper that controls everything that enters and exits. It’s the communication hub, receiving signals from hormones, neurotransmitters, and immune messengers. The health and fluidity of this membrane dictate the health of the cell, and by extension, the health of the entire organism.

The Omega-6 and Omega-3 Imbalance: Fueling the Fire

The cell membrane is primarily composed of a phospholipid bilayer. Embedded within this layer is our diet, which directly influences various types of fats and their composition. This is where the story of modern chronic disease truly begins, with two key players: Omega-6 fatty acids and Omega-3 fatty acids.
Both are polyunsaturated fatty acids (PUFAs) and are considered essential, meaning our bodies cannot produce them; we must obtain them from our food.

  • Omega-6 Fatty Acids: The primary Omega-6 is linoleic acid (LA), which is abundant in industrial seed oils like soybean, corn, safflower, and sunflower oil. When consumed, LA can be converted into arachidonic acid (AA).
  • Omega-3 Fatty acids: The primary plant-based Omega-3 is alpha-linolenic acid (ALA), found in flaxseeds, chia seeds, and walnuts. However, the most biologically active forms are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are found predominantly in fatty, cold-water fish and algae.

From an evolutionary perspective, our ancestors consumed a diet in which the ratio of Omega-6 to Omega-3 was approximately 1:1 or 2:1, providing a balanced inflammatory potential. The modern Western diet, however, has completely upended this balance. With the proliferation of processed foods and industrial seed oils, the average ratio today is estimated to range from 15:1 to 25:1.
This dramatic shift is not trivial. It has profound and devastating consequences for our cellular health. When the cell membrane is overloaded with arachidonic acid due to excess Omega-6s, the cell is primed for an aggressive inflammatory response. Think of it as having a pile of dry, flammable kindling surrounding every cell in your body.

Eicosanoids: The Messengers of Inflammation and Resolution

When a cell experiences stress or injury—whether from a physical trauma, a pathogen, or a toxin—enzymes like phospholipase A2 (PLA2) are activated. PLA2 cleaves fatty acids from the cell membrane, making them available for conversion into powerful signaling molecules called eicosanoids.
The type of eicosanoid produced depends entirely on the fatty acid that was cleaved:

  • From Arachidonic Acid (Omega-6): The enzymes cyclooxygenase (COX) and lipoxygenase (LOX) convert AA into highly pro-inflammatory eicosanoids. These include:
    • Prostaglandin E2 (PGE2): Promotes pain, fever, and inflammation. This is the target of NSAID drugs like ibuprofen.
    • Thromboxane A2 (TXA2): Promotes blood clotting and vasoconstriction.
    • Leukotriene B4 (LTB4): A powerful chemoattractant that recruits immune cells to the site of injury, amplifying the inflammatory response.
  • From EPA and DHA (Omega-3): These fatty acids are converted into a different class of signaling molecules that are either less inflammatory or, more importantly, are actively anti-inflammatory and pro-resolving.
    • EPA competes with AA for the same COX and LOX enzymes, producing less inflammatory prostaglandins (like PGE3) and leukotrienes (like LTB5).
    • Crucially, EPA and DHA are precursors to a specialized class of molecules known as Specialized Pro-resolving Mediators (SPMs). These include resolvins, protectins, and maresins.

Resolvins and Protectins: The “Off-Switch” for Inflammation

For decades, we believed that inflammation “faded away.” Groundbreaking research has shown this is incorrect. The resolution of inflammation is an active, highly orchestrated biological process, and SPMs are the conductors.
While the initial inflammatory response is essential for dealing with acute threats—clearing pathogens and debris—it is designed to be a short-term event. The problem in chronic disease is that this “on-switch” is stuck. The flood of Omega-6s keeps producing pro-inflammatory signals, while a deficiency of Omega-3s means we lack the raw materials to produce the “off-switch” signals.
Resolvins and protectins do not block inflammation in the way a drug like an NSAID does. Instead, they actively resolve it. Their functions include:

  • Stopping the recruitment of neutrophils (a type of inflammatory white blood cell).
  • Promoting the clearance of dead cells and debris by macrophages (a process called efferocytosis).
  • Enhancing microbial killing.
  • Reducing pain signals.

In my clinical practice, I see the effects of this imbalance daily. A patient with rheumatoid arthritis, for example, is experiencing a classic inflammatory cascade driven by an overabundance of pro-inflammatory eicosanoids. While conventional treatment might focus on suppressing the immune system or blocking the COX enzymes, a functional approach seeks to rebalance the underlying fatty acid composition of their cell membranes. By significantly increasing their intake of EPA and DHA and reducing their intake of industrial Omega-6s, we provide the body with the necessary building blocks to manufacture its own powerful, endogenous anti-inflammatory and resolvin agents. This is not just masking the symptoms; it is addressing the fire at its source.

The Gut: Your Body’s Grand Central Station


If the cell membrane is ground zero for inflammation, the gastrointestinal tract is the command center that often determines whether that inflammation becomes a local skirmish or a full-blown systemic war. The gut is far more than a simple tube for digestion. It houses over 70% of our immune system, contains a vast neural network often called the second brain,” and is home to a complex ecosystem of trillions of microorganisms known as the gut microbiome. The health of this intricate system is paramount to overall health, and its dysfunction is a root cause of countless chronic conditions I see in my clinic.

Intestinal Permeability: When the Wall Is Breached

The lining of our small intestine is a remarkable structure. It has the surface area of a tennis court, yet it is only one cell thick. This single layer of epithelial cells is held together by protein structures called tight junctions. These junctions act as a highly selective barrier, meticulously controlling what passes from the gut lumen into the bloodstream. In a healthy state, only fully digested nutrients, water, and electrolytes are allowed through.
Intestinal permeability, colloquially known as leaky gut,” occurs when these tight junctions become loose or damaged. This allows larger, undigested food particles, toxins, and bacterial components to “leak” into the bloodstream, where they do not belong.
When these foreign invaders enter the circulation, the immune system, which is heavily concentrated just on the other side of this gut wall (in an area called the Gut-Associated Lymphoid Tissue, or GALT), identifies them as hostile. It mounts a powerful immune response, releasing a flood of inflammatory cytokines like Tumor Necrosis Factor-alpha (TNF-α), Interleukin-6 (IL-6), and Interleukin-1 (IL-1).
This is a critical point: the inflammation is no longer contained within the gut. These cytokines travel throughout the body, creating a state of chronic, low-grade systemic inflammation.

  • This inflammation can manifest in the joints as arthritis.
  • It can cross the blood-brain barrier, contributing to brain fog, anxiety, depression, and even neurodegenerative diseases.
  • It can appear on the skin as eczema, psoriasis, or acne.
  • It can trigger or exacerbate autoimmune diseases like Hashimoto’s thyroiditis, lupus, or multiple sclerosis.

In our clinic, when a patient presents with widespread, seemingly unrelated symptoms, one of my first lines of inquiry is the patient’s gut health. A 45-year-old woman with joint pain, migraines, and fatigue might have been told she has fibromyalgia. But when we dig deeper, we often find a history of antibiotic use, a diet high in processed foods, and chronic stress—all major contributors to leaky gut.

The Role of Zonulin and Lipopolysaccharide (LPS)

Two key molecules are central to the science of leaky gut: zonulin and lipopolysaccharide (LPS).
Zonulin is a protein that acts as the primary modulator of tight junction function. It’s the “gatekeeper of the gut.” When zonulin levels rise, it signals the tight junctions to open. This is a normal physiological process to a degree, but certain triggers can cause a chronic overproduction of zonulin, leading to a persistently leaky gut. The two most well-documented triggers for zonulin release are:

  • Gliadin: A protein component of gluten. For a significant portion of the population, not just those with celiac disease, gliadin can trigger a zonulin response.
  • Gut Bacteria: Certain imbalances in gut flora can also stimulate zonulin release.

Lipopolysaccharide (LPS) is a component of the outer membrane of gram-negative bacteria, which are a normal part of the gut microbiome. LPS itself is not inherently “bad” when it stays within the gut lumen. However, when the gut barrier is compromised, LPS leaks into the bloodstream. This event is known as metabolic endotoxemia.
LPS is one of the most potent triggers of inflammation known to the human immune system. Even minuscule amounts in the bloodstream can set off a powerful inflammatory cascade. The immune system recognizes LPS via a receptor called Toll-like Receptor 4 (TLR4), which is found on immune cells such as macrophages. Activation of TLR4 triggers the massive release of pro-inflammatory cytokines, driving the systemic inflammation associated with insulin resistance, obesity, cardiovascular disease, and non-alcoholic fatty liver disease (NAFLD).
Therefore, a leaky gut creates a vicious cycle: gut barrier dysfunction allows LPS to enter the bloodstream, which causes systemic inflammation. This systemic inflammation, in turn, can further damage the gut lining, increasing its permeability and allowing even more LPS to leak through.

The Microbiome and the Estrobolome: Gut-Hormone Crosstalk

The gut is not just an immune and digestive organ; it is also a major endocrine (hormone-regulating) organ. The connection between gut health and hormonal balance is one of the most exciting and clinically relevant areas of modern research. This is particularly evident when we examine estrogen metabolism.

The Estrobolome: Your Gut’s Estrogen-Regulating Machinery

The estrobolome is a specific collection of bacteria within the gut microbiome that possesses a unique set of genes capable of metabolizing estrogens. These bacteria produce an enzyme called beta-glucuronidase. To understand its significance, we must first look at how the body eliminates estrogen.

  • Phase I & II Detoxification in the Liver: After estrogen has done its job in the body, it is sent to the liver for further processing before elimination. The liver modifies the estrogen and then attaches a glucuronic acid molecule to it in a process called glucuronidation. This “tags” the estrogen, making it water-soluble and ready for excretion via the bile, which is then released into the gut.
  • The Role of Beta-Glucuronidase: In a healthy gut with a balanced microbiome, this conjugated (tagged) estrogen passes through the intestines and is excreted in the stool. However, in a state of dysbiosis (an imbalanced microbiome), an overgrowth of certain bacteria can lead to high levels of the enzyme beta-glucuronidase.
  • Reactivation and Recirculation: Beta-glucuronidase acts like a pair of scissors. It cleaves the glucuronic acid tag off the estrogen. This “un-conjugates” the estrogen, converting it back into its active form. This free, active estrogen is now small enough to be reabsorbed from the gut back into the bloodstream.

This process undermines the body’s primary mechanism for clearing excess estrogen. The estrogen that was supposed to be eliminated is now recirculated, leading to an overall increase in the body’s estrogen load. This condition is known as estrogen dominance.

Clinical Implications of Estrogen Dominance

In my practice, estrogen dominance is a frequent finding in women presenting with a wide array of symptoms:

  • Premenstrual Syndrome (PMS): Severe mood swings, bloating, breast tenderness, and cramping.
  • Heavy or Irregular Menstrual Bleeding.
  • Uterine Fibroids and Endometriosis.
  • Fibrocystic Breasts.
  • Weight Gain: Particularly around the hips, thighs, and abdomen.
  • Increased Risk of Hormone-Sensitive Cancers: Such as breast, uterine, and ovarian cancer.

A patient may come to me seeking help for her debilitating PMS. The conventional approach might be to prescribe birth control pills to regulate her cycle or an SSRI for her mood symptoms. A functional medicine approach, however, asks why her hormones are imbalanced. By running a comprehensive stool analysis, we might discover elevated beta-glucuronidase levels, indicating an unhealthy estrobolome.
The treatment, therefore, is not to manipulate her hormones directly with synthetic drugs, but to heal her gut. By addressing dysbiosis, we can reduce beta-glucuronidase activity, allowing her body to excrete estrogen properly. This restores the natural balance between estrogen and progesterone, often resolving her symptoms at the source. This is a perfect example of how addressing a root cause in one system (the gut) can resolve symptoms in another (the endocrine system).

The Critical Role of Detoxification

The concepts of a leaky gut and a dysfunctional estrobolome highlight the immense burden placed on the body’s detoxification systems. Detoxification is not a trendy “cleanse” involving lemon water and cayenne pepper; it is a fundamental, continuous series of metabolic processes that the body uses to neutralize and eliminate harmful substances. These substances include not only external toxins from our environment (xenobiotics), such as pesticides, plastics, and heavy metals, but also internal byproducts of our own metabolism (endotoxins), such as hormones and inflammatory mediators.
The liver is the master organ of detoxification. This process is broadly divided into two phases, with a crucial third phase involving excretion.

Phase I Detoxification: The Activation Pathway

Phase I is the body’s first line of defense. It involves a family of enzymes known as the Cytochrome P450 (CYP450) superfamily. These enzymes use processes such as oxidation, reduction, and hydrolysis to transform fat-soluble toxins into more water-soluble forms.
Think of Phase I as taking a large, non-biodegradable piece of plastic and breaking it into smaller, more reactive pieces. This process is essential, but it can also be dangerous. The intermediate molecules created during Phase I are often more volatile and potentially more damaging (carcinogenic) than the original toxin. These are highly reactive molecules with unpaired electrons, known as free radicals.
This is why it’s critical that Phase II function optimally and immediately follow Phase I. An imbalance where Phase I is overactive and Phase II is sluggish can lead to a significant buildup of these toxic intermediates, causing cellular damage and increasing cancer risk.
Nutrients that support Phase I include:

  • B Vitamins: B2, B3, B6, B12, and folate.
  • Antioxidants: Vitamins A, C, and E, which help neutralize the free radicals produced.
  • Minerals: Such as iron and magnesium.

Phase II Detoxification: The Conjugation Pathway

Phase II is the conjugation (attachment) pathway. Its job is to take the highly reactive intermediates from Phase I and attach another molecule to them, making them water-soluble, non-toxic, and ready for excretion. There are several key Phase II pathways:

  • Glucuronidation: This is the primary pathway for detoxifying hormones (like estrogen), bilirubin, and many drugs. It involves attaching glucuronic acid. As we discussed, high beta-glucuronidase activity in the gut can reverse this process.
  • Sulfation: This pathway is crucial for detoxifying neurotransmitters, steroid hormones, and some xenobiotics. It requires sulfur-containing compounds. Patients with poor sulfation capacity may experience adverse reactions to sulfur-rich foods (such as garlic and onions) or supplements (such as MSM).
  • Glutathione Conjugation: Glutathione is the body’s master antioxidant and detoxifier. The enzyme glutathione S-transferase (GST) attaches glutathione to toxins, neutralizing them. This is a primary defense against heavy metals, pesticides, and the carcinogenic byproducts of Phase I.
  • Acetylation, Amino Acid Conjugation, and Methylation: These are additional important pathways that target specific toxins. Methylation, in particular, is a vast and critical biochemical process involved in everything from DNA expression to neurotransmitter synthesis and hormone clearance.

Key nutrients for supporting Phase II pathways are specific to each pathway:

  • Sulfation: Sulfur-rich amino acids like methionine and cysteine (found in eggs, cruciferous vegetables, garlic, onions), and molybdenum.
  • Glutathione Conjugation: N-acetylcysteine (NAC), glycine, glutamine, and selenium.
  • Methylation: Methionine, B12 (methylcobalamin), B6 (P-5-P), and folate (5-MTHF).

Phase III Detoxification: The Elimination Pathway

This Phase is often overlooked but is just as critical. Once toxins are conjugated in the liver, they must be transported out of the body. The primary routes are:

  • Bile: Fat-soluble toxins conjugated in the liver are released into bile, which flows into the small intestine and is then carried out of the body in the stool.
  • Urine: Water-soluble toxins are filtered by the kidneys and excreted in urine.

This is where gut health becomes paramount once again. If a person is chronically constipated, toxins released into the gut via bile are not eliminated efficiently. They can sit in the colon, where they may be reabsorbed back into circulation or be acted upon by gut bacteria (like the beta-glucuronidase we discussed), reversing the detoxification process. A healthy gut with regular bowel movements and adequate fiber to bind to toxins is essential for completing the detoxification cycle.
Clinically, I assess a patient’s detoxification capacity by reviewing their history and symptoms, and sometimes using advanced functional testing to measure the activity of these pathways. A person with chronic fatigue, chemical sensitivities, and hormonal imbalances is almost certainly dealing with a compromised detoxification system. Our therapeutic approach involves not just “detoxing” them, but systematically supporting each Phase with targeted nutrition, lifestyle changes, and botanicals to restore the body’s innate ability to clean house.

The 4R Program: A Systematic Approach to Gut Healing

Understanding the interconnectedness of inflammation, gut permeability, and detoxification provides us with a powerful “why.” The “how” is a systematic clinical protocol that has become a cornerstone of functional medicine: the 4R Program for gut restoration. This isn’t a quick fix; it’s a comprehensive, multi-phased approach designed to address the root causes of gut dysfunction and, by extension, a wide range of systemic health issues.
I guide my patients through this program step by step, customizing it to their unique physiology, history, and test results. It is a partnership that requires commitment from the patient and careful guidance from the clinician.

1. Remove

The first and most critical step is to remove the triggers that are driving inflammation and damaging the gut lining. We cannot hope to heal the gut while it is still under constant assault. This Phase involves two main components: dietary changes and pathogen eradication.
Dietary Removal:

  • The Elimination Diet: the gold standard for identifying food sensitivities. We typically remove the most common inflammatory triggers for 4-6 weeks. These include:
    • Gluten: Due to its potential to trigger zonulin release and its cross-reactivity with other proteins.
    • Dairy: Specifically, the casein and whey proteins, which are common allergens.
    • Soy: Often genetically modified and can be a gut irritant for many.
    • Corn: Another common allergen and source of pro-inflammatory Omega-6s.
    • Eggs, Nuts, and Nightshades (tomatoes, peppers, eggplant, potatoes): Removed in more sensitive individuals.
    • Processed Foods, Sugar, and Industrial Seed Oils (Omega-6s): These are non-negotiable removals as they are primary drivers of inflammation and gut dysbiosis.
  • The goal is to calm the immune system. After the elimination period, foods are reintroduced one by one, carefully monitoring for any return of symptoms. This process helps the patient create a personalized, long-term anti-inflammatory diet.


Pathogen Removal:

  • If stool testing reveals an overgrowth of pathogenic bacteria, yeast (such as Candida), or parasites, we must address it. This is often done using targeted antimicrobial therapy.
  • Herbal Antimicrobials: I often prefer to start with broad-spectrum herbal agents that are effective yet gentle on the host. These include berberine, oregano oil, garlic (allicin), and grapefruit seed extract. These botanicals often have the added benefit of disrupting biofilms, protective shields that colonies of bacteria and yeast form to hide from the immune system and antibiotics.
  • Pharmaceuticals: In some cases, targeted prescription antifungals (like Nystatin or Fluconazole) or antibiotics (like Rifaximin for Small Intestinal Bacterial Overgrowth, or SIBO) may be necessary.

2. Replace

Once we’ve removed the irritants, we need to ensure the body has what it needs for proper digestion and absorption. Chronic gut inflammation and poor diet can lead to deficiencies in essential digestive factors.

  • Stomach Acid (Hydrochloric Acid – HCl): Many people, especially as they age or under chronic stress, have low stomach acid (hypochlorhydria). This is a major problem, as adequate acid is needed to sterilize food, kill pathogens, and begin protein digestion. Without it, proteins putrefy in the gut, feeding the wrong bacteria, and minerals like iron, calcium, and B12 are poorly absorbed. We may use Betaine HCl with meals to support this.
  • Digestive Enzymes: A compromised pancreas or gut lining may not produce enough enzymes to break down fats, proteins, and carbohydrates. Supplementing with a broad-spectrum digestive enzyme formula can reduce bloating and gas and ensure that nutrients are properly broken down for absorption, preventing them from serving as food for pathogenic microbes.
  • Bile Support: Bile is essential for fat digestion and absorption of fat-soluble vitamins (A, D, E, K). It also acts as an antimicrobial agent in the small intestine. For patients who have had their gallbladder removed or who show signs of poor fat digestion (e.g., floating stools), supporting bile flow with compounds such as taurine, glycine, ox bile, or dandelion root can be very beneficial.

3. Reinoculate

With the gut environment cleared of major offenders and digestive function supported, it’s time to rebuild the beneficial microbial community. This is about restoring a diverse, balanced, and resilient microbiome.

  • Probiotics: These are live, beneficial bacteria. We use high-quality, multi-strain probiotics to help repopulate the gut. The key strains we look for include various species of Lactobacillus and Bifidobacterium. Under specific conditions, we might use targeted strains such as Saccharomyces boulardii, a beneficial yeast that is effective against Candida and C. difficile.
  • Prebiotics: These are the food for your good bacteria. Probiotics will not survive and thrive without adequate fuel. Prebiotics are specific types of fermentable fiber. Excellent food sources include Jerusalem artichokes, chicory root, garlic, onions, leeks, and asparagus. We can also supplement with prebiotic fibers such as inulin, Fructooligosaccharides (FOS), or Galactooligosaccharides (GOS), although we must introduce them slowly to avoid gas and bloating.

A diet rich in a wide variety of plant fibers is the best long-term strategy for maintaining a healthy microbiome. Each type of fiber feeds different species of bacteria, so diversity in your diet leads to diversity in your gut.

4. Repair

The final step is to provide the nutrients needed to heal and regenerate the gut lining, closing the “leaks” and restoring the barrier’s integrity. This Phase runs concurrently with the others, but its focus intensifies as the inflammation subsides.

  • L-Glutamine: This amino acid is the primary fuel source for the cells that line the small intestine (enterocytes). It is essential for repairing a leaky gut. Supplementing with L-glutamine provides the building blocks for these cells to regenerate and tighten the junctions between them.
  • Zinc Carnosine: This chelated compound has been extensively studied in Japan for the treatment of stomach ulcers and gut inflammation. It has a unique ability to adhere to the inflamed lining of the GI tract, where it provides sustained healing, reducing inflammation and promoting tissue repair.
  • Deglycyrrhizinated Licorice (DGL): This form of licorice has had the glycyrrhizin component removed (which can raise blood pressure). DGL is a powerful demulcent, meaning it soothes and coats the mucous membranes of the GI tract, reducing irritation and promoting the secretion of protective mucus.
  • Aloe Vera: Similar to DGL, aloe has potent anti-inflammatory and soothing properties that help heal the inflamed epithelial lining.
  • Omega-3 Fatty Acids (EPA/DHA): As discussed earlier, these fats are the precursors to the powerful anti-inflammatory and pro-resolving resolvins and protectins. High-dose fish oil is often a key part of the repair phase, actively turning off inflammatory signaling in the gut wall.
  • Bone Broth: Rich in collagen, gelatin, and amino acids like glycine and proline, bone broth provides a readily absorbable source of the raw materials needed to rebuild connective tissue, including the gut lining.

By systematically following the 4R Program, we can guide the body back to balance. We remove the insults, support natural digestive processes, rebuild the beneficial microbial army, and provide the raw materials for healing. This is the essence of functional medicine: understanding the body’s intricate systems and providing targeted support to help it heal itself.

Summary

This educational post, published on January 16, 2026, has journeyed through the core principles of modern functional medicine, presenting a systems-based view of health and chronic disease. We began by establishing the cell membrane as the fundamental battleground for inflammation. We learned that the dietary imbalance between pro-inflammatory Omega-6 fatty acids (from industrial seed oils) and anti-inflammatory Omega-3 fatty acids (from fish oil) primes our cells for chronic, low-grade inflammation. This imbalance disrupts the production of signaling molecules, favoring inflammatory eicosanoids over the crucial, inflammation-resolving resolvins and protectins. From there, we identified the gut as the epicenter of systemic health and dissected the mechanism of intestinal permeability, or “leaky gut.” We explored how damage to the gut’s single-cell-thick barrier allows inflammatory triggers, such as lipopolysaccharides (LPS), to enter the bloodstream, driving systemic inflammation that manifests as joint pain, brain fog, and autoimmune conditions. We further elucidated the gut’s role as an endocrine organ, focusing on the estrobolome—gut bacteria that regulate estrogen levels—and how dysfunction of the estrobolome can lead to estrogen dominance and related health issues. This led us to recognize the critical importance of the body’s liver detoxification pathways, which clear these inflammatory molecules and hormonal byproducts. Finally, we tied these concepts together with a practical, evidence-based clinical strategy: the 4R Program (Remove, Replace, Reinoculate, Repair), a systematic protocol for healing the gut, rebalancing the microbiome, and quenching the fires of chronic inflammation.

Conclusion


The paradigm of healthcare is shifting. The prevailing model of the 20th century, which often focused on managing symptoms with pharmaceuticals, is giving way to a more nuanced, root-cause-oriented approach. As both a chiropractor and a family nurse practitioner, I have seen firsthand the power of this integrated perspective. The conditions that plague modern society—autoimmune diseases, hormonal imbalances, chronic pain, metabolic syndrome, and neurocognitive issues—are not isolated pathologies. They are the downstream consequences of upstream dysfunctions, primarily rooted in chronic inflammation originating from our cells and our gut. By understanding the intricate biochemistry of fatty acids, the profound impact of gut barrier integrity, the complex interplay between the microbiome and our hormones, and the essential role of detoxification, we can intervene meaningfully. The 4R Program is not merely a protocol; it is a logical framework for restoring the body’s innate capacity for self-regulation and healing. The future of medicine lies in this personalized, systems-based approach, empowering patients and practitioners to build a foundation of true, resilient health from the cells up.

Key Insights

  • Cellular inflammation is the Foundation: The ratio of Omega-6 to Omega-3 fatty acids in your cell membranes dictates your body’s inflammatory tone. A diet high in processed foods and industrial seed oils directly induces a pro-inflammatory state at the cellular level, serving as the bedrock of most chronic diseases.
  • Leaky Gut Drives Systemic Disease: A compromised gut barrier is not a localized digestive issue; it is a primary driver of systemic inflammation. The leakage of bacterial components, such as LPS, into the bloodstream triggers body-wide immune activation that can manifest as arthritis, skin disorders, brain fog, and autoimmunity.
  • The Gut Regulates Your Hormones: The health of your gut microbiome, particularly the estrobolome, directly and profoundly affects your hormone balance. An imbalanced gut can lead to the recirculation of estrogen, contributing to estrogen dominance and a host of related symptoms and health risks.
  • Healing is a Systematic Process: Restoring health from chronic illness requires a structured approach. The 4R Program (Remove, Replace, Reinoculate, Repair) provides a comprehensive and effective framework for addressing the root causes of gut dysfunction, thereby resolving many systemic issues. It emphasizes removing inflammatory triggers, supporting digestion, rebuilding the microbiome, and providing key nutrients for tissue repair.

References

  • Serhan, C. N. (2014). Pro-resolving lipid mediators are leads for resolution physiology. Nature, 510(7503), 92–101.
  • Fasano, A. (2011). Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiological Reviews, 91(1), 151–175.
  • Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., … & Burcelin, R. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 56(7), 1761–1772.
  • Baker, J. M., Al-Nakkash, L., & Herbst-Kralovetz, M. M. (2017). Estrogen–gut microbiome axis: Physiological and clinical implications. Maturitas, 103, 45–53.
  • Liska, D. J. (1998). The detoxification enzyme systems. Alternative Medicine Review, 3(3), 187-198.
  • Bland, J. S., & Barrager, E. (2016). Clinical Approaches to Leaky Gut Syndrome (Intestinal Permeability). Institute for Functional Medicine.

Keywords

Inflammation, Omega-3 Fatty Acids, Cell Membrane, Leaky Gut, Intestinal Permeability, Gut Microbiome, Estrobolome, Estrogen, Dominance, Detoxification, 4R Program, Functional Medicine, Dr. Alexander Jimenez, Resolvins, Lipopolysaccharide (LPS), Zonulin

Disclaimer: This content is for informational and educational purposes only. It is not intended to provide medical advice or to replace medical advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. Neither Dr. Alexander Jimenez nor the publisher of this content takes responsibility for possible health consequences of any person or persons reading or following the information in this educational content.
Personal Medical Advice Disclaimer: All individuals must obtain recommendations for their personal health situations from their own medical providers. The information presented here is for educational purposes and should not be considered a substitute for consultation with a licensed healthcare professional.